Correlation Between 89bio and Structure Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 89bio and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 89bio and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 89bio Inc and Structure Therapeutics American, you can compare the effects of market volatilities on 89bio and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 89bio with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 89bio and Structure Therapeutics.

Diversification Opportunities for 89bio and Structure Therapeutics

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between 89bio and Structure is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding 89bio Inc and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and 89bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 89bio Inc are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of 89bio i.e., 89bio and Structure Therapeutics go up and down completely randomly.

Pair Corralation between 89bio and Structure Therapeutics

Given the investment horizon of 90 days 89bio Inc is expected to generate 1.2 times more return on investment than Structure Therapeutics. However, 89bio is 1.2 times more volatile than Structure Therapeutics American. It trades about 0.12 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.08 per unit of risk. If you would invest  777.00  in 89bio Inc on August 25, 2024 and sell it today you would earn a total of  99.00  from holding 89bio Inc or generate 12.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

89bio Inc  vs.  Structure Therapeutics America

 Performance 
       Timeline  
89bio Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 89bio Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 89bio is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Structure Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

89bio and Structure Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 89bio and Structure Therapeutics

The main advantage of trading using opposite 89bio and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 89bio position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.
The idea behind 89bio Inc and Structure Therapeutics American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges